Cure51, the Techbio company on a mission to decode the biology of exceptional cancer patients - the Outliers -  who survive aggressive cancers against all odds—today announces a successful ...

With lessons learned and management's heart in check, Intel is poised for an AI-era resurgence. Read why I rate INTC stock a ...